NCT00307710View on ClinicalTrials.gov

Influenza Vaccination in Patients Receiving Antineoplastic Therapy for Non-Hodgkin's Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
Lymphoma
Interventions
BIOLOGICAL

Trivalent Baculovirus-expressed Influenza HA vaccine

Receive either standard inactivated influenza vaccine or one of three doses of the experimental vaccine, vaccine dose 15, 45 or 135 μg HA per virus, intramuscular injection.

Trial Locations (1)

77030

U.T.M.D. Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT00307710 - Influenza Vaccination in Patients Receiving Antineoplastic Therapy for Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter